The medical device maker's adjusted earnings per share and revenue were more than expected, as sales of its cardiovascular products surged. Boston Scientific gave a mixed updated full-year forecast.
Medical-products company Boston Scientific reported third-quarter results before market open Shares of Boston Scientific Corp. rose 1.1% in premarket trades Wednesday after the medical products ...
We are impressed with Boston Scientific’s recent acquisitions that have added numerous products (though many ... its broad range of gastrointestinal (GI) and pulmonary treatment options.